Akari Therapeutics names Vatnak Vat-Ho chief business officer
AKTX•Akari Therapeutics named Vatnak Vat-Ho chief business officer. His priorities include advancing strategic collaborations, supporting investor engagement and translating scientific progress into long-term value.
1. Leadership appointment
Akari Therapeutics named Vatnak Vat-Ho chief business officer. His background includes oncology business development, strategic partnering and novel antibody-drug conjugate payload technologies.
2. Role priorities
Vat-Ho's priorities include advancing strategic collaborations, supporting investor engagement and translating scientific progress into long-term value.
